Delivery Order SPE2DB22D2218-SPE2DB25FR2NW
Award Date
5/15/25
Potential Completion Date
5/16/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,843.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OXCARBAZEPINE ER 150 MG TABLET 100S, a prescription medication, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 1, 2024. It is not designated as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $17,249.08 firm fixed-price delivery order is for the supply of OXCARBAZEPINE ER 600 MG TABLET 100S, a generic medication. The contract has an ultimate completion date of November 8, 2024 and was awarded on November 7, 2024. The performance location is Conshohocken, PA. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4566734673 OXCARBAZEPINE ER 600 MG TABLET 100S. The contract has a ceiling value of $5,945.20 and an ultimate completion date of December 17, 2024. This award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,135.08, is for the delivery of a specific pharmaceutical product, OXCARBAZEPINE 300 MG/5 ML SUSP 250ML, with an ultimate completion date of May 30, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA....
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,048.26, is for the delivery of 100 tablets of Oxcarbazepine ER 150 mg, a medication used to treat seizures. This is a Firm Fixed Price Delivery Order contract, with an ultimate completion date of January 24, 2025. The contract was awarded on January 23, 2025, and was not...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division located in Conshohocken, Pennsylvania. The contract, valued at $1,345.12, is for the provision of 4564249689 - OXCARBAZEPINE 300 MG/5 ML SUSP 250ML, a pharmaceutical product. This delivery order is issued under an existing indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that...
This federal contract award, with ID SPE2DB22D1202|SPE2DB25FUJK4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,482.78 firm fixed-price delivery order is for the supply of 4566420572 - OXCARBAZEPINE 300 MG TABLET 100S. The contract has an ultimate completion date of November 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,541.50 Firm Fixed Price Delivery Order is for the supply of 4566514910 OXCARBAZEPINE ER 300 MG TABLET 100S, with a period of performance through November 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, with a ceiling value of $2,176.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product OXCARBAZEPINE 300 MG/5 ML SUSP 250ML. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $3,890.30, is for the supply of 4,558,996,119 Oxcarbazepine 300 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the...